Journal Article Summary
The article investigates the chemical composition of vaping fluids recovered from patients diagnosed with E-cigarette or vaping product use-associated lung injury (EVALI) in New York State. EVALI is a serious lung condition that emerged in 2019 and has affected thousands of individuals across the United States. Understanding the components of vaping products, especially those from illicit sources, is crucial as these products may pose significant health risks, including respiratory injuries linked to harmful additives like vitamin E acetate (VEA).
The study analyzed 284 vaping devices from 83 EVALI patients, focusing on both nicotine and cannabis products. The researchers found that a significant portion of the cannabis vaping fluids contained VEA, which was detected in 65% of the samples. Additionally, many of these products were identified as illicit, lacking proper labeling and containing various diluents and pesticides. The findings suggest that the presence of VEA and other harmful substances in these vaping fluids could be contributing factors to the development of EVALI.
However, the study has limitations, including the possibility that not all vaping products used by patients were submitted for analysis, potentially leading to an incomplete understanding of exposure. Readers should be aware that while VEA has been strongly linked to EVALI, other components in vaping products may also pose health risks. It is essential for individuals using vaping products, especially those from unregulated sources, to discuss their use with a healthcare professional to better understand the potential dangers and make informed decisions regarding their health.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Lu Shijun (Jimmy), Li Lingyun, Duffy Bryan C., Dittmar Mark A., Durocher Lorie A., Panawennage Deepika, Delaney-Baldwin Em R., Spink David C.. Investigation of Vaping Fluids Recovered From New York State E-Cigarette or Vaping Product Use-Associated Lung Injury Patients. Frontiers in Chemistry 2021. DOI: 10.3389/fchem.2021.748935. PMID: 34778204. PMCID: PMC8579054.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
